...
首页> 外文期刊>Contraception >Second- and third-trimester termination of pregnancy in women with uterine scar - A retrospective analysis of 111 gemeprost-induced terminations of pregnancy after previous cesarean delivery
【24h】

Second- and third-trimester termination of pregnancy in women with uterine scar - A retrospective analysis of 111 gemeprost-induced terminations of pregnancy after previous cesarean delivery

机译:子宫瘢痕妇女的妊娠中期和妊娠中期-先前剖宫产后111吉美前列素引起的妊娠终止的回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: This study was conducted to evaluate and analyze the efficacy and safety of using gemeprost for second- and third-trimester termination of pregnancy (TOP) in women with uterine scar due to previous cesarean section. Study Design: Retrospective analysis of 111 medical TOPs for fetal anomaly or death at 14 to 34 weeks of gestation in women with a history of cesarean section was performed at a German tertiary care center from 2005 to 2009. Abortion was induced via intravaginal application of the prostaglandin analogue gemeprost (1 mg) every 6 h. Results: One hundred eleven women with one (89.2%) or two (10.8%) previous cesarean sections underwent medical TOP with gemeprost. The median induction-to-expulsion interval was 18 h 24 min (range, 2 h 20 min-168 h 28 min), and in 34 (30.6%) cases, the induction interval was longer than 24 h. The overall incidence of severe complications was 9/111 (8.1%), including one case of silent uterine rupture (with the need for blood transfusion), four cases of atonic and three secondary hemorrhages and one case of peritonitis due to uterine perforation during curettage. Failure of induction (induction-to- expulsion >48 h) occurred in 11 cases (9.9%). Conclusion: Gemeprost-induced TOP in the second and third trimester in women with uterine scar due to previous cesarean section is effective and has a low complication rate.
机译:背景:本研究旨在评估和分析吉米前列素治疗因先前剖宫产而引起的子宫瘢痕妇女的妊娠中晚期(TOP)的有效性和安全性。研究设计:2005年至2009年在德国三级医疗中心对有剖宫产史的妇女在妊娠14至34周时的111例胎儿异常或死亡的医学TOPs进行了回顾性分析。每6小时服用前列腺素类似物吉普列斯特(1 mg)。结果:一百一十一例有一次剖宫产(89.2%)或两例(10.8%)剖宫产的女性接受了吉普前列素的医学治疗。中位驱逐间隔时间为18 h 24 min(范围为2 h 20 min-168 h 28 min),在34(30.6%)的情况下,诱导间隔大于24 h。严重并发症的总发生率为9/111(8.1%),其中包括1例无声子宫破裂(需要输血),4例失音和3次继发性出血以及1例因刮宫期间子宫穿孔而引起的腹膜炎。 11例(9.9%)发生了诱导失败(诱导-驱逐> 48 h)。结论:吉美前列素引起的子宫剖宫产前子宫瘢痕妇女的妊娠中期和中期TOP有效且并发症发生率低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号